Brief: Phaxiam Announces Intention To Voluntary Delist American Depositary Shares From The Nasdaq Capital Market
Feb 20 (Reuters) - Phaxiam Therapeutics SA PHXM.PA :
* PHAXIAM THERAPEUTICS ANNOUNCES INTENTION TO VOLUNTARY
DELIST
AMERICAN DEPOSITARY SHARES FROM THE NASDAQ CAPITAL MARKET
* PHAXIAM THERAPEUTICS SA: ADS DELISTING IS ANTICIPATED TO
BE
EFFECTIVE PRIOR TO OPENING OF TRADING ON MARCH 11, 2024
Source text for Eikon: ID:nGNX4FqBFl
Further company coverage: PHXM.PA
(Reuters.Briefs@thomsonreuters.com)
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure